These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25043934)

  • 41. Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study.
    Mitaka C; Kusao M; Kawagoe I; Satoh D; Iba T; Ronco C
    Blood Purif; 2022; 51(1):62-69. PubMed ID: 33910191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation.
    Shimizu T; Hanasawa K; Sato K; Umeki M; Koga N; Naganuma T; Sato S; Shimonishi T; Ikeda T; Matsuno N; Ono S; Saitoh H; Satoh K; Otani Y; Endo Y; Eguchi Y; Tani T;
    Langenbecks Arch Surg; 2009 Mar; 394(2):303-11. PubMed ID: 18685861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A study on the mechanism of enhanced diuresis following direct hemoperfusion with polymyxin B-immobilized fiber].
    Terawaki H; Kasai K; Kobayashi H; Hirano K; Hamaguchi A; Kase Y; Horiguchi T; Yokoyama K; Yamamoto H; Nakayama M; Kawaguchi Y; Hosoya T
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):359-64. PubMed ID: 10998916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients with Septic Shock.
    Inoue S; Sakamoto Y; Koami H; Yamada C K; Nagashima F; Miike T; Iwamura T; Obata T
    J Nippon Med Sch; 2018; 85(1):39-46. PubMed ID: 29540645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome.
    Tsushima K; Kubo K; Yoshikawa S; Koizumi T; Yasuo M; Furuya S; Hora K
    Ther Apher Dial; 2007 Apr; 11(2):138-45. PubMed ID: 17381535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
    Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
    BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.
    Klein DJ; Foster D; Schorr CA; Kazempour K; Walker PM; Dellinger RP
    Trials; 2014 Jun; 15():218. PubMed ID: 24916483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
    Aoki H; Tani T; Hanasawa K; Shoji H; Kodama M
    Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):775-80. PubMed ID: 8377751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted therapy using polymyxin B hemadsorption in patients with sepsis: a post-hoc analysis of the JSEPTIC-DIC study and the EUPHRATES trial.
    Osawa I; Goto T; Kudo D; Hayakawa M; Yamakawa K; Kushimoto S; Foster DM; Kellum JA; Doi K
    Crit Care; 2023 Jun; 27(1):245. PubMed ID: 37344804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in serum S100A12 and sRAGE associated with improvement of the PaO(2)/FiO(2) ratio following PMX-DHP therapy for postoperative septic shock.
    Takahashi G; Hoshikawa K; Matsumoto N; Shozushima T; Onodera C; Kan S; Akitomi S; Kikkawa T; Tomisawa Y; Kojika M; Sato N; Inoue Y; Suzuki K; Wakabayashi G; Endo S
    Eur Surg Res; 2011; 47(3):135-40. PubMed ID: 21921634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature.
    Cruz DN; de Cal M; Piccinni P; Ronco C
    Contrib Nephrol; 2010; 167():77-82. PubMed ID: 20519901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endotoxin removal by polymyxin B immobilized cartridge inactivates circulating proapoptotic factors.
    Martin EL; Ranieri VM
    Contrib Nephrol; 2010; 167():65-76. PubMed ID: 20519900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
    Aoki H; Kodama M; Tani T; Hanasawa K
    Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment in endotoxemic pigs.
    Koami H; Sakamoto Y; Miyasho T; Itami T; Tamura J; Ishizuka T; Kawamura Y; Nakamura K; Miyoshi K; Yamashita K
    J Nippon Med Sch; 2014; 81(3):130-8. PubMed ID: 24998959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure.
    Matsuno N; Ikeda T; Ikeda K; Hama K; Iwamoto H; Uchiyama M; Kozaki K; Narumi Y; Kikuchi K; Degawa H; Nagao T
    Ther Apher; 2001 Feb; 5(1):36-9. PubMed ID: 11258608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymyxin B-immobilized fiber hemoperfusion with low priming volume in an elderly septic shock patient with marked endotoxemia.
    Nakamura T; Kawagoe Y; Ueda Y; Koide H
    ASAIO J; 2005; 51(4):482-4. PubMed ID: 16156319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of direct hemoperfusion with polymyxin B immobilized cartridge on meropenem in critically ill patients requiring renal support.
    Singhan W; Vadcharavivad S; Areepium N; Wittayalertpanya S; Chaijamorn W; Srisawat N
    J Crit Care; 2019 Jun; 51():71-76. PubMed ID: 30769293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymyxin B hemoperfusion prevents acute kidney injury in sepsis model.
    Mitaka C; Masuda T; Kido K; Uchida T; Abe S; Miyasho T; Tomita M; Inada E
    J Surg Res; 2016 Mar; 201(1):59-68. PubMed ID: 26850185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endotoxin removal: how far from the evidence? The EUPHAS 2 Project.
    Martin EL; Cruz DN; Monti G; Casella G; Vesconi S; Ranieri VM; Ronco C; Antonelli M
    Contrib Nephrol; 2010; 167():119-125. PubMed ID: 20519906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.